Generated by GPT-5-mini| WHO Review Committee on the Functioning of the International Health Regulations | |
|---|---|
| Name | WHO Review Committee on the Functioning of the International Health Regulations |
| Formation | 2011 |
| Type | Advisory committee |
| Headquarters | Geneva |
| Parent organization | World Health Organization |
| Region served | Global |
WHO Review Committee on the Functioning of the International Health Regulations
The WHO Review Committee on the Functioning of the International Health Regulations was an ad hoc expert body convened by the World Health Organization to assess implementation of the International Health Regulations (2005). It operated at the intersection of global health governance, public health law and international relations, producing evaluations that informed decisions by the World Health Assembly, United Nations agencies, and national public health institutes such as the Centers for Disease Control and Prevention and Public Health England.
The committee was created after debates at the World Health Assembly and in response to high-profile public health events including the 2009 swine flu pandemic, the 2014 West African Ebola epidemic, and critiques stemming from the Global Health Security Agenda. Its establishment built on precedents such as the Independent Panel on Pandemic Influenza Preparedness and lessons from reviews of the Severe Acute Respiratory Syndrome response led by regional bodies like the European Centre for Disease Prevention and Control and national commissions such as the U.S. National Academy of Medicine studies. The committee convened experts drawn from networks linked to institutions like the Johns Hopkins Bloomberg School of Public Health, the London School of Hygiene & Tropical Medicine, and the Pasteur Institute.
The committee’s mandate focused on evaluating how the International Health Regulations (2005) functioned during acute events and routine implementation. Objectives included assessing notification obligations under Article 6, evaluating the role of the Director-General of the World Health Organization in declaring a Public Health Emergency of International Concern, and examining coordination among stakeholders such as the United Nations Children's Fund, the International Committee of the Red Cross, and national ministries like the Ministry of Health (Brazil). It aimed to recommend legal, operational, and technical reforms to strengthen surveillance systems used by laboratories such as the Robert Koch Institute and networks like the Global Outbreak Alert and Response Network.
Membership comprised senior public health officials, epidemiologists, legal scholars, and representatives from intergovernmental organizations. Notable institutional affiliations among members included the Harvard T.H. Chan School of Public Health, the World Bank, the Bill & Melinda Gates Foundation, and the Gavi, the Vaccine Alliance. The committee worked with WHO technical departments and liaised with commissions such as the Independent Oversight and Advisory Committee and panels convened by the European Commission. It reported to the Director-General of the World Health Organization and to delegations at the World Health Assembly.
The committee applied mixed methods: systematic document review, case study analyses of events like the 2016 Zika virus epidemic and the 2018–2020 Kivu Ebola epidemic, stakeholder interviews with officials from the African Union and the Association of Southeast Asian Nations, and field missions to affected countries including Sierra Leone and Democratic Republic of the Congo. It used legal analysis grounded in instruments such as the Vienna Convention on the Law of Treaties and technical assessment tools developed with partners like the World Organisation for Animal Health and the Food and Agriculture Organization of the United Nations. Findings were synthesized into formal reports presented at sessions of the World Health Assembly.
The committee identified delays in event detection, inconsistent use of national focal points, and ambiguities in reporting thresholds that affected timely notification under the International Health Regulations (2005). It recommended clarifying the criteria for declaring a Public Health Emergency of International Concern, strengthening capacities under the IHR core capacities framework, and enhancing data sharing with platforms such as the Global Health Security Index. Recommendations included bolstering funding mechanisms through multilateral partners like the International Monetary Fund and operationalizing rapid response teams akin to concepts used by the United Nations Office for the Coordination of Humanitarian Affairs.
Following the committee’s reports, the World Health Assembly adopted resolutions urging member states to accelerate IHR implementation, and WHO implemented guidance updates for national focal points and emergency committees. Changes influenced the structuring of WHO’s Health Emergencies Programme and informed reforms proposed to the WHO Pandemic Treaty discussions and amendments to the International Health Regulations (2005). The committee’s work affected donor strategies by entities such as the Global Fund to Fight AIDS, Tuberculosis and Malaria and informed training curricula at institutions including the African Field Epidemiology Network.
Critics argued the committee’s recommendations were insufficiently binding, pointing to continued delays in national compliance and alleged political pressures from member states including China, United States, and Russia during review processes. Scholars from the London School of Economics and commentators in outlets referencing the Lancet raised concerns about transparency, conflicts of interest involving philanthropic actors like the Bill & Melinda Gates Foundation, and the balance between WHO authority and state sovereignty. Debates during successive World Health Assembly sessions highlighted tensions between technical recommendations and the feasibility of legal amendments under the Vienna Convention on the Law of Treaties.